Surgical Science

Vol.9 No.10(2018), Paper ID 87712, 9 pages

DOI:10.4236/ss.2018.910043

 

Conversion of Unresectable to Resectable Liver Metastases from Colorectal Carcinoma Using Hepatic Arterial Chronomodulated Chemotherapy: A Case Report and Short Literature Review

 

Evgeny Y. Parnes, Maria S. Sayapina, Alexey A. Tryakin, Mohamed Bouchahda, Pasquale F. Innominato, Jean-Francois Morere, Francis A. Levi, Rene Adam

 

The Central Clinical Hospital of Civil Aviation, Moscow, Russia
N.N. Blokhin Russian Oncology Research Center, Moscow, Russia
N.N. Blokhin Russian Oncology Research Center, Moscow, Russia
Department of Medical Oncology, Assistance Publique Hôpitaux de Paris, Hôpital Paul Brousse, Villejuif, France
INSERM UMRS 776 “Biological Rhythms and Cancers”, Campus CNRS, Villejuif, France
Department of Medical Oncology, Assistance Publique Hôpitaux de Paris, Hôpital Paul Brousse, Villejuif, France
Cancer Chronotherapy Team, Warwick Medical School, Coventry, United Kingdom
Hepato-Biliary Center, Assistance Publique Hôpitaux de Paris, Hôpital Paul Brousse, Villejuif, France

 

Copyright © 2018 Evgeny Y. Parnes, Maria S. Sayapina, Alexey A. Tryakin, Mohamed Bouchahda, Pasquale F. Innominato, Jean-Francois Morere, Francis A. Levi, Rene Adam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Y. Parnes, E. , Sayapina, M. , Tryakin, A. , Bouchahda, M. , Innominato, P. , Morere, J. , Levi, F. and Adam, R. (2018) Conversion of Unresectable to Resectable Liver Metastases from Colorectal Carcinoma Using Hepatic Arterial Chronomodulated Chemotherapy: A Case Report and Short Literature Review. Surgical Science, 9, 358-366. doi: 10.4236/ss.2018.910043.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.